Limited coverage drugs – duloxetine
Last updated on August 20, 2024
|
Generic name |
duloxetine |
|---|---|
|
Strength |
30 mg, 60 mg |
|
Form |
delayed-release capsules |
|
Special Authority criteria |
Approval period |
|---|---|
|
For the treatment of neuropathic pain in adult patients, when the patient has had an inadequate response to trials of gabapentin and at least 1 tricyclic antidepressant agent. |
Indefinite |
Practitioner exemptions
- None
Special notes
- Special Authority coverage of duloxetine for the treatment of neuropathic pain is available for up to a maximum dose of 60 mg/day
- PharmaCare also covers duloxetine for patients enrolled in Plan P, BC Palliative Care Benefits Program, as a regular benefit at a maximum dose of 60 mg/day